박셀바이오: directors' dealings · South Korea · DART (FSS)

Explore the full directors' dealings record of 박셀바이오, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 박셀바이오 has recorded 1 public disclosures. Market capitalisation: €145.1bn. The latest transaction was disclosed on 27 March 2026 (Purchase). Among the most active insiders: 정성창. All data is free.